Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Adult 1
- Anti-HIV Agents 1
- Antiretroviral Therapy, Highly Active 1
- Article 1
- Bleeding scores 1
- Carriers 1
- Drug Monitoring 1
- Female 1
- Health Care Costs 1
- Health Personnel 1
- Health Resources 1
- Hemophilia B 1
- HIV Infections 1
- Humans 1
- Interviews as Topic 1
- Malawi 1
- Male 1
- Mathematical model 1
- Perception 1
- Thrombin generation 1
- Viral Load 1
- Workload 1
Personal Author
Resource Type General
Keywords
- Algorithms 1
- Antitubercular Agents 1
- CD4 Lymphocyte Count 1
- Cost-Benefit Analysis 1
- Drug Resistance, Bacterial 1
- economic analysis 1
- HIV 1
- HIV Infections 1
- Humans 1
- intensified TB case finding 1
- Isoniazid 1
- isoniazid 1
- Models, Economic 1
- MTB/RIF 1
- Mycobacterium tuberculosis 1
- provider perceptions 1
- Radiography 1
- resource-limited settings 1
- Rifampin 1
- Sensitivity and Specificity 1
- Tuberculosis 1
- viral load monitoring 1
- Xpert® 1
Select all docs (Max 200)
1 -
3 of 3 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Adult (1)
- Anti-HIV Agents (1)
- Antiretroviral Therapy, Highly Active (1)
- Article (1)
- Bleeding scores (1)
- Carriers (1)
- Drug Monitoring (1)
- Female (1)
- Health Care Costs (1)
- Health Personnel (1)
- Health Resources (1)
- Hemophilia B (1)
- HIV Infections (1)
- Humans (1)
- Interviews as Topic (1)
- Malawi (1)
- Male (1)
- Mathematical model (1)
- Perception (1)
- Thrombin generation (1)
- Viral Load (1)
- Workload (1)
- Algorithms (1)
- Antitubercular Agents (1)
- CD4 Lymphocyte Count (1)
- Cost-Benefit Analysis (1)
- Drug Resistance, Bacterial (1)
- economic analysis (1)
- HIV (1)
- HIV Infections (1)
- Humans (1)
- intensified TB case finding (1)
- Isoniazid (1)
- isoniazid (1)
- Models, Economic (1)
- MTB/RIF (1)
- Mycobacterium tuberculosis (1)
- provider perceptions (1)
- Radiography (1)
- resource-limited settings (1)
- Rifampin (1)
- Sensitivity and Specificity (1)
- Tuberculosis (1)
- viral load monitoring (1)
- Xpert® (1)
- :Gupta, S. ;Abimbola, T.10 2014 | Int J Tuberc Lung Dis. 18(10):1159-1165:OBJECTIVETo evaluate the cost-effectiveness of the Three I’s for HW/TB (human immunodeficiency virus/tuberculosis): antiretroviral therapy (ART), in...
- :Gupta, S. ;Bravo, M.C.August 08 2019 | Thromb Res. 182:43-50:IntroductionFactor IX:C (FIX:C) levels vary in hemophilia B carriers even in pedigrees with a unifying genetic defect. Analyzing the balance between p...
- :Rutstein, S.E. ;Golin, C.1 2016 | AIDS Care. 28(1):1-10:Scale-up of viral load (VL) monitoring for HIV-infected patients on antiretroviral therapy (ART) is a priority in many resource-limited settings, and ...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.